ANGION BIOMEDICA CORP (ANGN) Stock Analyst Earnings Estimates
NASDAQ:ANGN - Nasdaq - US03476J1079 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.88M 93.29% | 28.312M 883.06% | 2.301M -91.87% | -100.00% | |||
| EBITDA YoY % growth | -55.17M -43.15% | -39.216M 28.92% | -30.258M 22.84% | -41.83M -38.25% | -46.657M -11.54% | N/A | |
| EBIT YoY % growth | -55.27M -43.22% | -39.307M 28.88% | -30.436M 22.57% | -25.5M 16.22% | -20.4M 20.00% | -20.4M | |
| Operating Margin | -1,919.10% | -138.84% | -1,322.73% | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -2.09 64.67% | -1.29 38.28% | -0.85 34.37% | -0.54 36.14% | -0.45 16.98% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | -0.21 -136.21% | -0.21 | 0.00 | 1.96% |
| Q3 2022 Q2Q % growth | -0.30 43.40% | -0.37 | 0.07 | 18.30% |
| Q2 2022 Q2Q % growth | -0.30 48.28% | -0.47 | 0.17 | 36.52% |
| Q1 2022 Q2Q % growth | -0.48 69.23% | -0.44 | -0.04 | -8.18% |
| Q4 2021 Q2Q % growth | 0.58 130.53% | -0.63 | 1.21 | 192.09% |
| Q3 2021 Q2Q % growth | -0.53 | -0.74 | 0.21 | 28.33% |
| Q2 2021 Q2Q % growth | -0.58 | -0.70 | 0.12 | 17.29% |
| Q1 2021 Q2Q % growth | -1.56 | -0.63 | -0.93 | -145.69% |
| Q4 2020 Q2Q % growth | -1.90 | -1.33 | -0.57 | -43.29% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | -100.00% | % | ||
| Q3 2022 Q2Q % growth | -100.00% | 833.003K | -833.003K | -100.00% |
| Q2 2022 Q2Q % growth | 653K 20.93% | 1.377M | -724K | -52.58% |
| Q1 2022 Q2Q % growth | 1.648M 345.41% | 937.125K | 710.875K | 75.86% |
| Q4 2021 Q2Q % growth | 25.941M 5,539.35% | 1.772M | 24.169M | 1,363.94% |
| Q3 2021 Q2Q % growth | 1.46M -39.69% | 1.084M | 376K | 34.69% |
| Q2 2021 Q2Q % growth | 540K -25.93% | 476.003K | 63.997K | 13.44% |
| Q1 2021 Q2Q % growth | 370K | 1.925M | -1.555M | -80.78% |
| Q4 2020 Q2Q % growth | 460K -34.29% | 1.938M | -1.478M | -76.26% |
| Q3 2020 Q2Q % growth | 2.421M 206.07% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |